14 According to our patent searches, Novo Nordisk has filed 91 patents for formulations, 41 patents covering devices to deliver the drug, and 45 patents for methods of treatment (Figure 6)
Dual-Action Formula: Unlike other drugs, Mounjaro targets both blood sugar and appetite control
These medications work by influencing hormones that regulate appetite and blood sugar, leading to reduced calorie intake and increased feelings of fullness
Insurance Is Plan-Specific Coverage varies by diagnosis, employer exclusion, formulary, prior authorization, indication, pharmacy benefit, and the exact product
Visceral adipose tissue overrelease free fatty acids, proinflammatory cytokines (including TNF- and IL-6), and dysregulated adipokines (manifested as increased leptin and decreased adiponectin levels), collectively establishing a state of chronic low-grade inflammation (7173)